Literature DB >> 34907730

A biochemical approach to the anti-inflammatory, antioxidant and antiapoptotic potential of beta-carotene as a protective agent against bromobenzene-induced hepatotoxicity in female Wistar albino rats.

Priya Josson Akkara1,2, Evan Prince Sabina1.   

Abstract

Bromobenzene is a compound which has contributed much in understanding the mechanisms involved in xenobiotic hepatotoxicity induced by drugs and environment pollutants. In the present study, the protective and ameliorative effect of beta-carotene was investigated against bromobenzene-induced hepatotoxicity and compared with silymarin, a standard hepatoprotective reference drug. Beta-carotene (10 mg/kg b.w. p.o.) was administered to the rats for 9 days before intragastric intubation of bromobenzene (10 mmol/kg b.w.). Liver marker enzymes (aspartate transaminase, alanine transaminase and alkaline phosphatase), total protein content, bilirubin, total cholesterol, high-density lipoproteins, triglycerides, antioxidant status (reduced glutathione, superoxide dismutase, catalase, glutathione-S-transferase and glutathione peroxidase) were assessed along with histopathological analysis. ELISA was performed for analysing the levels of cytokines such as TNF-α, IL-1β and IL-6 in serum and in the liver. Caspase-3, COX-2 and NF-κB were evaluated by Western blotting. Administration of bromobenzene resulted in elevated levels of liver marker enzymes, bilirubin, lipid peroxidation and cytokines but deterioration in total protein content, antioxidant levels and histopathological conditions. Pre-treatment with beta-carotene not only significantly decreased the levels of liver markers, lipid peroxidation and cytokines but also improved histo-architecture and increased antioxidant levels minimising oxidative stress, and reduced factors contributing to apoptosis. This significant reversal of the biochemical changes on pre-treatment with beta-carotene in comparison with rats administered with bromobenzene clearly demonstrates that beta-carotene possesses promising hepatoprotective effect through its antioxidant, anti-inflammatory and antiapoptotic activity and hence is suggested as a potential therapeutic agent for protection from bromobenzene.

Entities:  

Keywords:  Antioxidant; Beta-carotene; Bromobenzene; Cytokines; Hepatotoxicity; Oxidative stress

Mesh:

Substances:

Year:  2020        PMID: 34907730     DOI: 10.32725/jab.2020.011

Source DB:  PubMed          Journal:  J Appl Biomed        ISSN: 1214-021X            Impact factor:   1.797


  37 in total

Review 1.  Oxidative stress is bane in chronic liver diseases: Clinical and experimental perspective.

Authors:  Devaraj Ezhilarasan
Journal:  Arab J Gastroenterol       Date:  2018-05-28       Impact factor: 2.076

Review 2.  Association between intake of antioxidants and pancreatic cancer risk: a meta-analysis.

Authors:  Jiamin Chen; Wuxia Jiang; Liming Shao; Dandan Zhong; Yihua Wu; Jianting Cai
Journal:  Int J Food Sci Nutr       Date:  2016-06-30       Impact factor: 3.833

Review 3.  Eugenol and Its Role in Chronic Diseases.

Authors:  S Fujisawa; Y Murakami
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

4.  Renoprotective effects of the crude extract and solvent fractions of the leaves of Euclea divinorum Hierns against gentamicin-induced nephrotoxicity in rats.

Authors:  Tadiwos Feyissa; Kaleab Asres; Ephrem Engidawork
Journal:  J Ethnopharmacol       Date:  2012-12-08       Impact factor: 4.360

5.  β-carotene and retinol reduce benzo[a]pyrene-induced mutagenicity and oxidative stress via transcriptional modulation of xenobiotic metabolizing enzymes in human HepG2 cell line.

Authors:  Wageh Sobhy Darwish; Yoshinori Ikenaka; Shouta Nakayama; Hazuki Mizukawa; Lesa A Thompson; Mayumi Ishizuka
Journal:  Environ Sci Pollut Res Int       Date:  2017-12-15       Impact factor: 4.223

6.  Beta-carotene as a novel therapy for the treatment of "Autistic like behavior" in animal models of Autism.

Authors:  Yosefa Avraham; Elliot M Berry; Marina Donskoy; Wiessam Abu Ahmad; Lia Vorobiev; Amnon Albeck; David Mankuta
Journal:  Behav Brain Res       Date:  2017-09-28       Impact factor: 3.332

7.  Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence.

Authors:  Andrea Arena; Till S Zimmer; Jackelien van Scheppingen; Anatoly Korotkov; Jasper J Anink; Angelika Mühlebner; Floor E Jansen; Wim van Hecke; Wim G Spliet; Peter C van Rijen; Annamaria Vezzani; Johannes C Baayen; Sander Idema; Anand M Iyer; Marzia Perluigi; James D Mills; Erwin A van Vliet; Eleonora Aronica
Journal:  Brain Pathol       Date:  2018-11-20       Impact factor: 6.508

8.  Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial.

Authors:  Michael W Fried; Victor J Navarro; Nezam Afdhal; Steven H Belle; Abdus S Wahed; Roy L Hawke; Edward Doo; Catherine M Meyers; K Rajender Reddy
Journal:  JAMA       Date:  2012-07-18       Impact factor: 56.272

9.  Targeting the mitochondrial apoptosis pathway by a newly synthesized COX-2 inhibitor in pediatric ALL lymphocytes.

Authors:  Marjan Aghvami; Ahmad Salimi; Peyman Eshghi; Mohammad H Zarei; Shabnam Farzaneh; Fatemeh Sattari; Afshin Zarghi; Jalal Pourahmad
Journal:  Future Med Chem       Date:  2018-10-11       Impact factor: 3.808

10.  Protective effects of curcumin and beta-carotene on cisplatin-induced cardiotoxicity: An experimental rat model.

Authors:  Anzel Bahadır; Ayşe Ceyhan; Özlem Öz Gergin; Betül Yalçın; Menekşe Ülger; Tuğçe Merve Özyazgan; Arzu Yay
Journal:  Anatol J Cardiol       Date:  2018-03       Impact factor: 1.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.